LifeMD Inc (LFMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LifeMD Inc (LFMD) has a cash flow conversion efficiency ratio of -0.142x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.28 Million) by net assets ($23.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LFMD equity financing ratio to measure how much of total assets are equity-financed.
LifeMD Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how LifeMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LFMD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
LifeMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LifeMD Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Toro Ltd
LSE:TORO
|
0.025x |
|
Eagle Nuclear Energy Corp. Common stock
NASDAQ:NUCL
|
-0.039x |
|
Cash Converters International
AU:CCV
|
0.102x |
|
Northern Minerals Ltd
AU:NTU
|
-6.457x |
|
Voyager Therapeutics Inc
NASDAQ:VYGR
|
-0.141x |
|
TON Strategy Co
NASDAQ:TONX
|
-0.015x |
|
NOVAREX Co.Ltd
KQ:194700
|
0.041x |
|
SHANGH.DAZ.PUBL.UTIL.YC 1
F:6WL
|
N/A |
Annual Cash Flow Conversion Efficiency for LifeMD Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of LifeMD Inc from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of LifeMD Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.16 Million | $8.28 Million | 0.358x | +108.26% |
| 2024-12-31 | $-4.05 Million | $17.51 Million | -4.329x | -373.20% |
| 2023-12-31 | $5.57 Million | $8.82 Million | 1.585x | -49.53% |
| 2022-12-31 | $-7.31 Million | $-22.94 Million | 3.139x | +344.99% |
| 2021-12-31 | $25.82 Million | $-33.09 Million | -1.281x | -108.68% |
| 2020-12-31 | $-821.76K | $-12.13 Million | 14.763x | +6731.00% |
| 2019-12-31 | $-1.13 Million | $251.41K | -0.223x | +79.85% |
| 2018-12-31 | $819.74K | $-905.52K | -1.105x | +15.81% |
| 2017-12-31 | $622.84K | $-817.22K | -1.312x | -216.35% |
| 2016-12-31 | $-361.73K | $-407.91K | 1.128x | +169.16% |
| 2015-12-31 | $180.99K | $-295.12K | -1.631x | -580.24% |
| 2014-12-31 | $-139.50K | $33.44K | -0.240x | +81.91% |
| 2013-12-31 | $195.49K | $-259.07K | -1.325x | +22.12% |
| 2012-12-31 | $135.00K | $-229.73K | -1.702x | -2822.77% |
| 2011-12-31 | $-282.98K | $-17.69K | 0.062x | -- |
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature e… Read more